VERA
Vera Therapeutics, Inc. Class A Common StockstockNASDAQ
Market OpenNov 19, 2026 3:11:17 PM EST
26.40USD+3.206%(+0.82)617,863
VERA Financials
In Q3 FY 2026 (ended ), Vera Therapeutics, Inc. Class A Common Stock (VERA) reported revenue of $10.28M, net income of −$93.71M, operating cash flow of −$99.18M, and assets of $465.75M (filed ).
Loading financial statements…